INSTIL BIO, INC.

(TIL)
  Report
Delayed Nasdaq  -  04:00 2022-07-05 pm EDT
5.150 USD   +8.42%
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell 3000E Growth Index
CI
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell 3000 Growth Index
CI
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell Small Cap Comp Growth Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Instil Bio Shares Drop 35% After FDA IND Clearance and Truist Price Target Cut

05/27/2022 | 01:14pm EDT

By Josh Beckerman


Instil Bio Inc. shares were down 35% to $5.16 Friday afternoon.

Earlier Friday, the biopharmaceutical said that it received investigational new drug clearance from the U.S. Food and Drug Administration for ITIL-306, Instil's first genetically-engineered Costimulatory Antigen Receptor TIL therapy.

The company also said it will present findings from studies of anti-FOLR1 CoStAR T cells on June 5.

Truist lowered its price target on the shares to $25 from $32. Analyst Asthika Goonewardene said Truist updated its model following the company's May 16 earnings report.

Truist lowered its "peak 3L melanoma share" for the company to 20% from 30%.


Write to Josh Beckerman at josh.beckerman@wsj.com


(END) Dow Jones Newswires

05-27-22 1313ET

Stocks mentioned in the article
ChangeLast1st jan.
COSTAR GROUP CO., LTD. -1.66% 14.79 End-of-day quote.-33.20%
COSTAR GROUP, INC. 0.90% 61.87 Delayed Quote.-22.41%
INSTIL BIO, INC. 8.42% 5.15 Delayed Quote.-72.24%
All news about INSTIL BIO, INC.
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell 3000E Growth Index
CI
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell 3000 Growth Index
CI
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell Small Cap Comp Growth Index
CI
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell 2000 Growth Index
CI
06/24INSTIL BIO, INC.(NASDAQGS : TIL) dropped from Russell 2500 Growth Index
CI
06/13INSTIL BIO, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financ..
AQ
06/06Morgan Stanley Adjusts Instil Bio's Price Target to $9 From $14, Keeps Equalweight Rati..
MT
05/27INSTIL BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/27Instil Bio Shares Drop 35% After FDA IND Clearance and Truist Price Target Cut
DJ
05/27Instil Bio Receives IND Clearance from FDA for First CoStAR-TIL program - Shares Tumble
MT
More news
Analyst Recommendations on INSTIL BIO, INC.
More recommendations
Financials (USD)
Sales 2022 0,33 M - -
Net income 2022 -218 M - -
Net cash 2022 210 M - -
P/E ratio 2022 -3,04x
Yield 2022 -
Capitalization 614 M 614 M -
EV / Sales 2022 1 210x
EV / Sales 2023 554x
Nbr of Employees 437
Free-Float 97,6%
Chart INSTIL BIO, INC.
Duration : Period :
Instil Bio, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSTIL BIO, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 5,15 $
Average target price 24,75 $
Spread / Average Target 381%
EPS Revisions
Managers and Directors
Bronson Crouch Chairman & Chief Executive Officer
Sandeep Laumas Chief Financial & Business Officer
Zachary Roberts Chief Medical Officer
Vijay Chiruvolu Chief Technical Officer
George Matcham Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INSTIL BIO, INC.-72.24%614
MODERNA, INC.-40.96%59 644
IQVIA HOLDINGS INC.-23.78%40 704
LONZA GROUP AG-31.09%40 503
SEAGEN INC.16.50%33 154
CELLTRION, INC.-7.58%19 151